Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor‑positive/human epidermal growth factor receptor type 2 negative breast cancer
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.